Evidence map›Paper›PMID 37516770›Full record

ArticleScientific reports2023

Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram.

Ibrahim Karabayir, Fatma Gunturkun, Liam Butler, Samuel M Goldman, Rishikesan Kamaleswaran, Robert L Davis, Kalea Colletta, Lokesh Chinthala, John L Jefferies, Kathleen Bobay and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 1 country.

Ibrahim KarabayirCardiovascular Section, Department of Internal Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
Fatma GunturkunQuantitative Sciences Unit, Department of Medicine, Stanford University, Palo Alto, CA, USA.
Liam ButlerCardiovascular Section, Department of Internal Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
Samuel M GoldmanDivision of Occupational, Environmental, and Climate Medicine, San Francisco Veterans Affairs Medical Center, University of California-San Francisco, 4150 Clement Street, Box 127, San Francisco, CA, 94121, USA. samuel.goldman@ucsf.edu.
Rishikesan KamaleswaranDepartment of Biomedical Informatics, Emory University, Atlanta, GA, USA.
Robert L DavisCenter for Biomedical Informatics, University of Tennessee Health Science Center, Memphis, USA.
Kalea CollettaDepartment of Neurology, Edward Hines Jr. VA Hospital, Hines, IL, USA.
Lokesh ChinthalaCenter for Biomedical Informatics, University of Tennessee Health Science Center, Memphis, USA.
John L JefferiesDepartment of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Kathleen BobayParkinson School of Health Sciences and Public Health, Loyola University Chicago, Maywood, IL, USA.
G Webster RossVeterans Affairs Pacific Islands Health Care Systems, Honolulu, HI, USA.
Helen PetrovitchPacific Health Research and Education Institute, Honolulu, HI, USA.
Kamal MasakiKuakini Medical Center, Honolulu, HI, USA.
Caroline M TannerDepartment of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Oguz AkbilgicCardiovascular Section, Department of Internal Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA. oakbilgi@wakehealth.edu.
University of Tennessee Health Science Center · USWake Forest University · USEdward Hines, Jr. VA Hospital · USEmory University · USKuakini Medical Center · USLoyola University Chicago · USPacific Health Research and Education Institute · USSan Francisco VA Medical Center · USStanford University · USUniversity of California, San Francisco · USVA Pacific Islands Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known about electrocardiogram (ECG) markers of Parkinson's disease (PD) during the prodromal stage. The aim of the study was to build a generalizable ECG-based fully automatic artificial intelligence (AI) model to predict PD risk during the prodromal stage, up to 5 years before disease diagnosis. This case-control study included samples from Loyola University Chicago (LUC) and University of Tennessee-Methodist Le Bonheur Healthcare (MLH). Cases and controls were matched according to specific characteristics (date, age, sex and race). Clinical data were available from May, 2014 onward at LUC and from January, 2015 onward at MLH, while the ECG data were available as early as 1990 in both institutes. PD was denoted by at least two primary diagnostic codes (ICD9 332.0; ICD10 G20) at least 30 days apart. PD incidence date was defined as the earliest of first PD diagnostic code or PD-related medication prescription. ECGs obtained at least 6 months before PD incidence date were modeled to predict a subsequent diagnosis of PD within three time windows: 6 months-1 year, 6 months-3 years, and 6 months-5 years. We applied a novel deep neural network using standard 10-s 12-lead ECGs to predict PD risk at the prodromal phase. This model was compared to multiple feature engineering-based models. Subgroup analyses for sex, race and age were also performed. Our primary prediction model was a one-dimensional convolutional neural network (1D-CNN) that was built using 131 cases and 1058 controls from MLH, and externally validated on 29 cases and 165 controls from LUC. The model was trained on 90% of the MLH data, internally validated on the remaining 10% and externally validated on LUC data. The best performing model resulted in an external validation AUC of 0.67 when predicting future PD at any time between 6 months and 5 years after the ECG. Accuracy increased when restricted to ECGs obtained within 6 months to 3 years before PD diagnosis (AUC 0.69) and was highest when predicting future PD within 6 months to 1 year (AUC 0.74). The 1D-CNN model based on raw ECG data outperformed multiple models built using more standard ECG feature engineering approaches. These results demonstrate that a predictive model developed in one cohort using only raw 10-s ECGs can effectively classify individuals with prodromal PD in an independent cohort, particularly closer to disease diagnosis. Standard ECGs may help identify individuals with prodromal PD for cost-effective population-level early detection and inclusion in disease-modifying therapeutic trials.

Indexed as

Deep LearningParkinson DiseaseArtificial IntelligenceCase-Control StudiesElectrocardiographyHumansProdromal Symptoms

Identifiers

PMID37516770
PMCPMC10387090
OpenAlexW4385380678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.